Thornhill Medical Ramps Up Production of MADM™, its Mobile Gas Anesthesia Technology Built for Extreme Conditions

Thornhill Medical’s Mobile Anesthesia Delivery Module (MADM™)

Thornhill Medical Ramps Up Production of MADM™, its Mobile Gas Anesthesia Technology Built for Extreme Conditions.

TORONTO, Nov. 22, 2023 (GLOBE NEWSWIRE) — Thornhill Medical today announced that it is accelerating its manufacturing of its MADM™ mobile anesthesia delivery technology. As current and future global conflicts and humanitarian crises grow, military and humanitarian medical teams need lighter, compact, and more portable medical equipment that can withstand austere, extreme, and unpredictable deployment environments.

Approved by both FDA and Health Canada, MADM™ easily connects to any ventilator to safely and accurately enable gas anesthesia. The lightweight and compact design of MADM™ make it ideal in more challenging environments such as field hospitals and forward-deployed surgical scenarios. MADM™ is quick to set up, easy to use, and has a small footprint – exactly what is required when time and space are at a premium, and mobility is required.

At just 7.1 lbs (excluding battery), MADM™ is about the size of a 2-slice toaster and can easily be hand-carried or attached to Thornhill Medical’s MOVES® SLC™ integrated life-support system to quickly and efficiently stand up a forward surgical capability.

When MADM™ is paired with the circle-circuit ventilator and oxygen generator embedded in MOVES® SLC™, MADM™ can reuse gas anesthesia, providing an elegant means to decrease anesthesia consumption. This proprietary MOVES® SLC™ circle-circuit removes the need for large amounts of compressed oxygen that may not be available when facing the tyranny of distance or other logistics challenges.

“We know that surgical care in the far-forward setting needs solutions that promote agility, mobility and are self-sufficient while overcoming contested logistics and supply chain interruptions,” says Lesley Gouldie, President and CEO of Thornhill Medical. “We are also experiencing an increased demand for our MOVES® SLC™ integrated life-support system which is why it is imperative that we are ready to support our combat and humanitarian partners to help save more lives with our companion MADM™ technology.”

New White Paper Examines Role of MADM™ in Patient Care

Since its initial development with the US Marine Corps (USMC) as its Field Anesthesia System, MADM™ has been deployed in critical care scenarios, including in Ukraine. A new white paper details the experience of fielding MADM™ and MOVES® SLC™ in a recent humanitarian surgical mission.

Entitled “MADM™, Mobile Anesthesia Delivery Module, a solution to filling Capabilities Gaps,” the paper explores how Thornhill Medical’s MADM™ technology addresses current and future capability gaps and examines the benefits of safe and effective gas anesthesia delivery far forward on the battlefield. The white paper also explores the role that next-generation portable anesthesia technology can play in supporting better patient outcomes and war fighter care.
Request a copy of the white paper here.
MOVES® SLC™ and MADM™ from Thornhill Medical are available to purchase on GSA Advantage, sold through ADS, Inc. in the US.

For more information, please contact: Kathleen Powderley, kathleen@responsiblecomm.ca, 416-803-5597.

About Thornhill Medical

A global innovator in respiratory and oxygen-related scientific research and advanced technologies, Thornhill Medical is transforming the delivery of critical care in austere and unpredictable combat casualty care and humanitarian environments. Its flagship micro-integrated life support system with built-in oxygen supply, MOVES® SLC™, and its companion anesthesia solution MADM™, are solving critical care capabilities gaps to save lives. Drawing on 20 years of pioneering scientific and engineering innovations that address the needs of health systems and providers, Thornhill Medical is unlocking tomorrow’s medical technology solutions, today. The team is pushing the boundaries of what’s technologically possible in interoperability, remote or autonomous delivery and the use of AI, and is developing solutions that can transform vascular diagnostics through arterial blood gas control. Thornhill Medical collaborates each day with customers, innovation leaders, industry, hospital, and military partners in more than 19 countries and in 65+ research institutes.

For more information: www.thornhillmedical.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/31c529e4-d5af-49b6-ae02-4c4984fba393

Staff

Recent Posts

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

36 minutes ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

2 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

16 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

19 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

19 hours ago